The role of parathyroid hormone (pth) in the 6-month prognosis of patients with chronic heart failure hospitalized in the cardiac unit of university hospitals of ahvaz city in 2015-2016

Seyed Mohammad Hassan Adel, Sarvenaz Soltani, Zhiva Taherpour


Background and aim:Chronic heart failure (CHF) syndrome is the most common cause of hospitalization in patients over 65 years of age. HF is a clinical disorder that occurs due to impairment in the structure or function of the heart as inherent or acquired, and causes clinical symptoms. Therefore, the purpose of this study was to evaluate the role of parathyroid hormone (PTH) in the 6-month prognosis of patients with chronic heart failure hospitalized in the cardiac unit of university hospitals of Ahvaz city in 2015-2016. Materials and methods: This study is a descriptive epidemiologic study. In this study, a total of 202 people were enrolled in the study, of which 126 (62.3%) were male and 76 (37.6%) were female, and patients classified for HF according to Framingham criteria and in the subgroup of systolic HF (with an ejection fraction of less than or equal to 40%) and hospitalized in the heart unit of Imam Khomeini Hospital in Ahvaz during the year 2015-2016 were enrolled in the study. Findings: The results showed that the chance of stroke and death in people with a PTH of more than 39 pg/ml is 5.85 times more than those with PTH of less than 39 pg/ml, and with the rise in the NYHA, PTH has also increased.Discussion and Conclusion: According to the evaluations conducted in this study, it was found that PTH is related to the severity of heart failure and subsequently its short-term prognosis. Therefore, it seems that during the first hospitalization of patients with heart failure, measurement of PTH can play a significant role in clarifying patients' clinical condition and predicting their short-term prognosis, and subsequently changing of the therapeutic route.


Heart failure, NYHA class, PTH

Full Text:



Bonow,Mann,Zippes.Braunwald’s heart disease. 2012; chap 27: p-517.

Shuang Z , et al. Correlations between serum intact Parathyroid Hormone (PTH) and N-terminal-Pro brain Natriuretic Peptide levels in elderly patients with Chronic Heart Failure (CHF). Archives of Gerontology and geriatrics. 2015; 60: 359-365.

Stewart AL , et al. Functional status and well-being of patients with chronic conditions: results from the medical outcomes study. JAMA. 1989; 262 :907–13.

McMurray JJ, Stewart S. The burden of heart failure. Eur Heart J. 2003; 5(suppl):3–14.

Ford I , et al. Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate : the shift risk model. International journal of cardiology .2015 ; 184 : 163-169.

Braunwald E. Biomarkers in heart failure. N Engl J med. 2008; 358: 2148-59.

Stevenson LW, et al. Target heart failure populations for newer therapies. Circulation. 1995; 92((suppl II)):174–181.

Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000; 102: 14-23.

Sabatine MS, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndrome: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation.2002; 105: 1760–1763.

Bonow, Mann, Zippes.Braunwald’s heart disease. 2012;chap26;p-509.

Gruson D, Ahn S, Rousseal M. Multiple biomarker strategy based on Parathyroid hormone and Natriuretic peptides testing for improved prognosis of chronic heart failure.Peptides.2015 ; 64 : 24-48.

Smogorzewski M. PTH, chronic renal failure and myocardium. Miner Electrolyte Metab . 1995; 21:55-62.

Ogino K, Burkhoff D, Bilezikian JP.The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 1995; 136:3024- 30.

Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998;37: 34-41.

Liang K, Oveisi F, Vaziri ND. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Kidney Int.1998; 53: 626-630.

Akmal M, Massry SG, Goldstein DA.Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest. 1985;75:1037-44.

Gurson D, Buglioni A , Burnett Jr. PTH : potential role in management of heart failure.Clinica Chimia Acta. 2014;433 : 290-296.

Razzolini R, Dllin C. Gender differences in heart failure. Italy gender specific med. 2015; 1:15-20.

Bauters , et al. Influence of diabetes mellitus on heart failure risk and outcome. Cardivascular Diabetology2:10.

Jagasia D, Mcnulty PH. Diabetes mellitus and heart failure. CHF.2003;9(3).

Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure: Is therr a place for Erythropoitin and intravenous iron?. J Neohrol. 2004 ; 17(6): 749-761.

Coats AJ. Anemia and heart failure. Heart. 2004; 90(9) : 977-979.

Tang YD, Katz SD. Anemia in choronic heart failure. Circulation. 2006 ; 113: 2454-61.

Groenveld HF, et al. Anemia and mortality in heart failure patients. Journal of the American collage of cardiology. 2008; 52(10): 818-827.

Flaherty JD, et al. Acute heart failure syndromes in patients with coronary artery disease. Journal of the American collage of cardiology. 2009; 53(3) : 254-263.

Ahmed A, Aronow WS, Fleg JL. Higher Newyork heart association classes and Increased mortality and hospitalization in heart failure patients with preserved left ventricular function. AM Heart J. 2006 ; 151(2): 444-445.

Loncar G, et al. Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. J Endocrinol Invest 2011; 34: 78-85.

Sugimoto T. Serum Intact Parathyroid Hormone levels predict hospitalization for heart failure. Heart. 2009; 95: 395-98.

Bansal N, et al. Serum Parathyroid hormone and 25-hydroxy vitamin D concentrations and risk of incident heart failure : The multi-ethnic study of atherosclerosis.JAHA . 2014 ; 3 : e001278doi .10.1161/JAHA.114.001278.

Wu Gy , et al. Serum parathyroid hormone levels predict hospitalization in outPatients of heart failure : a preliminary study. Zhonghua Yi Za Zhi.2013; 28 : 2205-2208.

Altay H, et al. Relation of serum parathyroid hormone level to severity of heart failure. AM J Cardiology. 2012; 109(2) : 252-260.

ALEKSEEVA E.M., CHERNOV A.V., Implicit Features of Associating Life Situations with Mental States, Astra Salvensis, Supplement No. 2, 2017, p. 619.

OKRIASHVILI T.G., The State of Private Law in the Modern Legal Society, Astra Salvensis, Supplement No. 2, 2017, p. 539.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Revista Publicando.

Licencia de Creative Commons


This Content is available under licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.